Drawing for IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION

USPTO serial 79383166

IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION

Reviewed by CopyMark Law Group

Reg. 7726114Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
POWERS, ALEXANDER L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMMUNEBIOTICS PROBIOTIC CONSORTIA DESIGNED WITH PHARMACEUTICAL PRECISION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley D. Crose

Bradley D. Crose Crose Law LLC112 Northbrooke TraceWoodstock, GA 30188United States

Goods and services

ClassDescriptionStatusFirst use
001Bacteriological preparations, other than for medical and veterinary use; ferments for industrial purposes, probiotic bacteria for use in the manufacture of food supplementsACTIVE—
005Probiotic bacterial formulations for medical use; probiotic supplements; food supplements; bacteriological preparations for medical purposes; probiotic preparations for medical use to help maintain a natural balance of the flora of the digestive system; pharmaceutical preparations treating and preventing conditions associated with gastrointestinal disorders; dietetic preparations adapted for medical and pharmaceutical purposes, namely, probiotic bacterial and bacterial cultures.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 26, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 25, 2025FIMPFINAL DISPOSITION PROCESSED—
Jun 18, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 3, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 15, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 15, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 6, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jan 6, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 6, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 6, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 26, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 26, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 25, 2024ALIEASSIGNED TO LIE—
Jun 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 4, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2024DOCKASSIGNED TO EXAMINER—
Feb 3, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 21, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance